Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Tennessee's Medicaid program, TennCare, covers drugs like Ozempic and Mounjaro to treat those with diabetes and heart ...

As GLP-1 drugs like Ozempic soar in popularity for weight loss, this film follows three people on their own GLP-1 journeys and explores how decades of diet culture and society’s relentless pursuit of ...

Driving business growth through innovative food and nutrition strategies for CPG & foodservice brands. 💡 The Rise of GLP-1 ...

TUESDAY, Nov. 19, 2024 (HealthDay News) -- More than half of all American adults, almost 137 million people, could be ...

Coya Therapeutics (COYA) releases the following letter to stockholders from Chief Executive Officer Dr. Arun Swaminathan….”Given my recent ...

The holidays are near, and so is the season of eating decadent meals – and sometimes, overeating. Overindulging on food is ...

Three-fourths of U.S. adults are now overweight or have obesity, with nearly 260 million predicted to have overweight or ...

The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...

Ozempic, Mounjaro and other weight loss drugs can have nasty side effects, and reducing the volume of food you eat will also ...